No clinical or demographics explained as much variance in the FIQR total as any of the mindfulness subscales .
Fibromyalgia patients experience symptoms that may be alleviated by mindfulness interventions .
Baseline values for the observe subscale of the FFMQ were unexpectedly high .
CONTEXT AND OBJECTIVE A growing body of literature suggests that mindfulness techniques may be beneficial in fibromyalgia .
A recent systematic review and meta- analysis of six trials indicated improvement in depressive symptoms and quality of life , calling for increased rigor and use of st and ardized measures in future trials .
The purpose of the study was to examine the relationship between mindfulness [ as measured by the Five Facet Mindfulness Question naire ( FFMQ ) ] and fibromyalgia impact [ as measured by the Revised Fibromyalgia Impact Question naire ( FIQR ) ] .
The effect of dietary glutamate on fibromyalgia and irritable bowel symptoms.
OBJECTIVES To examine the effects of a challenge with monosodium glutamate ( MSG ) as compared to placebo on the symptoms of fibromyalgia ( FM ) , in participants who initially experienced > 30 % remission of symptoms on an excitotoxin elimination diet . METHODS Fifty-seven FM patients who also had irritable bowel syndrome ( IBS ) were placed on a 4-week diet that excluded dietary additive excitotoxins including MSG and aspartame .  Thirty-seven people completed the diet and 84 % of those reported that > 30 % of their symptoms resolved , thus making them eligible to proceed to challenges . Subjects who improved on the diet were then r and omised to a 2-week double-blind placebo-controlled crossover challenge with MSG or placebo for 3 consecutive days each week . The primary outcome measure was total symptom score . Secondary outcome measures included visual analogue pain scales ( VAS for FM and IBS ) , an IBS Quality of Life Question naire ( IBS QOL ) and the Fibromyalgia Impact Question naire-Revised ( FIQR ) . Repeated measures ANOVA was used to analyse crossover challenge results . RESULTS The MSG challenge , as compared to placebo , result ed in a significant return of symptoms ( total symptom score , p<0.02 ) ; a worsening of fibromyalgia severity as determined by the FIQR ( p<0.03 ) ; decreased quality of life in regards to IBS symptoms ( IBS QOL , p<0.05 ) ; and a non-significant trend toward worsening FM pain based on visual analogue scale ( VAS , p<0.07 ) . CONCLUSIONS These findings suggest that dietary glutamate may be contributing to FM symptoms in some patients . Future research on the role of dietary excitotoxins in FM is warranted
No clinical or demographics explained as much variance in the FIQR total as any of the mindfulness subscales .
Fibromyalgia patients experience symptoms that may be alleviated by mindfulness interventions .
Baseline values for the observe subscale of the FFMQ were unexpectedly high .
CONTEXT AND OBJECTIVE A growing body of literature suggests that mindfulness techniques may be beneficial in fibromyalgia .
A recent systematic review and meta- analysis of six trials indicated improvement in depressive symptoms and quality of life , calling for increased rigor and use of st and ardized measures in future trials .
The purpose of the study was to examine the relationship between mindfulness [ as measured by the Five Facet Mindfulness Question naire ( FFMQ ) ] and fibromyalgia impact [ as measured by the Revised Fibromyalgia Impact Question naire ( FIQR ) ] .